PCH
CERE
Polar Capital Holdings’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-10,762
| Closed | -$235K | – | 312 |
|
|
2023
Q3 | $235K | Sell |
10,762
-900,000
| -99% | -$19.6M | ﹤0.01% | 272 |
|
|
2023
Q2 | $29M | Buy |
910,762
+142,486
| +19% | +$4.53M | 0.15% | 121 |
|
|
2023
Q1 | $18.7M | Buy |
768,276
+296,961
| +63% | +$7.24M | 0.12% | 143 |
|
|
2022
Q4 | $14.9M | Sell |
471,315
-46,961
| -9% | -$1.48M | 0.12% | 169 |
|
|
2022
Q3 | $14.6K | Buy |
518,276
+18,276
| +4% | +$516 | 0.09% | 163 |
|
|
2022
Q2 | $13.2K | Sell |
500,000
-250,000
| -33% | -$6.61K | 0.08% | 176 |
|
|
2022
Q1 | $26.3K | Hold |
750,000
| – | – | 0.12% | 143 |
|
|
2021
Q4 | $24.3K | Hold |
750,000
| – | – | 0.09% | 151 |
|
|
2021
Q3 | $22.1K | Buy |
750,000
+700,000
| +1,400% | +$20.7K | 0.09% | 159 |
|
|
2021
Q2 | $1.28K | Buy |
+50,000
| New | +$1.28K | 0.01% | 314 |
|